Log in to your Inderes Free account to see all free content on this page.

Inify Laboratories

Less than 1K followers

INIFY

Euronext Growth Oslo

Medical Equipment & Services

Health Care

Overview

Ownership

Investor consensus

Inify Laboratories provides cancer diagnostics through pathology laboratory services. The company uses a digital, standardized workflow for response times and quality assurance, initially in prostate diagnostics. Customers primarily consist of laboratories and hospitals. Inify Laboratories was founded in 2022 and is headquartered in Stockholm, Sweden.

Market cap

-

Turnover

-

Revenue

EBIT %

P/E

Dividend yield-%

Financial calendar

25.2.

2026

Annual report '25

29.4.

2026

Interim report Q1'26

20.5.

2026

General meeting '26

All

Press releases

ShowingAll content types

Regulatory press release12/4/2025, 12:07 PM

INIFY: Bulletin from the extraordinary general meeting of Inify Laboratories AB

Inify Laboratories

Regulatory press release12/4/2025, 12:06 PM

Bulletin from the extraordinary general meeting of Inify Laboratories AB

Inify Laboratories

Regulatory press release12/3/2025, 12:30 PM

Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue

Inify Laboratories

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release12/3/2025, 12:30 PM

Inify Laboratories AB: Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue

Inify Laboratories

Regulatory press release11/28/2025, 9:57 AM

INIFY: Financial calendar

Inify Laboratories

Regulatory press release11/12/2025, 2:09 PM

Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025

Inify Laboratories

Regulatory press release11/12/2025, 2:09 PM

Inify Laboratories AB: Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025

Inify Laboratories

Regulatory press release11/12/2025, 9:50 AM

Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million

Inify Laboratories

Regulatory press release11/12/2025, 9:50 AM

Inify Laboratories AB: Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million

Inify Laboratories

Regulatory press release10/29/2025, 10:15 AM

Correction - Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Inify Laboratories

Regulatory press release10/29/2025, 10:15 AM

Inify Laboratories AB: Correction - Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Inify Laboratories

Regulatory press release10/29/2025, 7:00 AM

Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Inify Laboratories

Regulatory press release10/29/2025, 7:00 AM

Inify Laboratories AB: Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Inify Laboratories

Regulatory press release8/29/2025, 9:56 AM

Inify Laboratories - mandatory notification of trade

Inify Laboratories

Regulatory press release8/29/2025, 9:56 AM

Inify Laboratories AB: Inify Laboratories - mandatory notification of trade

Inify Laboratories

Regulatory press release8/27/2025, 6:00 AM

Inify Laboratories: Solid growth in Sweden and first patient diagnostics delivered in the UK

Inify Laboratories

Regulatory press release8/27/2025, 6:00 AM

Inify Laboratories AB: Inify Laboratories: Solid growth in Sweden and first patient diagnostics delivered in the UK

Inify Laboratories

Regulatory press release5/21/2025, 6:00 AM

Inify Laboratories AB (publ) - summary of Annual General Meeting

Inify Laboratories

Regulatory press release5/21/2025, 6:00 AM

Inify Laboratories AB (publ) - summary of Annual General Meeting

Inify Laboratories

Regulatory press release4/30/2025, 6:00 AM

Inify Laboratories: Continued strong growth - construction and establishment in the UK

Inify Laboratories

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.